• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    UPLC-MS/MS for the determination of azilsartan in beagle dog plasma and its applicationin a pharmacokinetics study

    2015-05-15 13:09:24ChengGongJunfengWngYinghuSunDweiDingLuZhongMengZhuJinSunXingrongZhng

    Cheng Gong,Junfeng Wng,Yinghu Sun,*,Dwei Ding,Lu Zhong, Meng Zhu,Jin Sun,Xingrong Zhng,**

    aShenyang Pharmaceutical University,No.103,Wenhua Road,Shenyang 110016,ChinabShandong Weigao Pharm.Co.Ltd.,Weihai 264200,China

    Short Communication

    UPLC-MS/MS for the determination of azilsartan in beagle dog plasma and its application
    in a pharmacokinetics study

    Cheng Gonga,Junfeng Wangb,Yinghua Suna,*,Dawei Dinga,Lu Zhonga, Meng Zhua,Jin Suna,Xiangrong Zhanga,**

    aShenyang Pharmaceutical University,No.103,Wenhua Road,Shenyang 110016,ChinabShandong Weigao Pharm.Co.Ltd.,Weihai 264200,China

    ARTICLEINFO

    Article history:

    Received 15 May 2014

    Received in revised form

    13 October 2014

    Accepted 23 October 2014

    Available online 20 December 2014

    Azilsartan

    The purpose of the study is to develop an ultra performance liquid chromatographytandem mass spectrometry(UPLC-MS/MS)to determinate the concentration of azilsartan in the dog plasma.After precipitated by methanol,the plasma sample containing azilsartan and diazepam(internal standard,IS)was determined by UPLC-MS/MS.The mobile phase consisted of acetonitrile-water was pumped at a f l ow rate of 0.3 ml/min in gradient elution.Kinetex 2.6 μ XB-C18 column(50×2.1 mm,100 ?;Phenomenex,USA) were used for LC separations.The column temperature was 30°C and the injection volume was 5 μl.The electrospray ionization(ESI)and multiple reaction monitoring(MRM)were applied at the transitions of m/z 457→279(azilsartan)and m/z 285→193(diazepam), respectively.The developed method was identif i ed a good linearity over a concentration range of 2.5-5000 ng/ml.The lower limit of quantitation(LLOQ)was 2.5 ng/ml.The intraday and inter-day precision(relative standard deviation,RSD%)were less than 10%and accuracy(relative error,RE%)was less than 5%at three quality control levels.The extraction recovery of azilsartan at three quality control levels were 82.41±0.68%, 98.66±11.00%,102.43±0.82%.And the recovery for IS(100 ng/ml)was 91.75±0.54%.A validated UPLC-MS/MS method was f i rstly developed for the quantif i cation of azilsartan in dog plasma and it was applied to the pharmacokinetics study.

    ?2015 Shenyang Pharmaceutical University.Production and hosting by Elsevier B.V.This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/ licenses/by-nc-nd/4.0/).

    1.Introduction

    Azilsartan,a new generation of angiotensin II receptor blocker(ARB),was successfully developed by Takeda in 2012 and the trade name is Azilva?.It is the main active metabolite of azilsartan medoxomil[1]which was approved as an antihypertention drug by US Food and Drug Administration (FDA)in 2011.Azilsartan selectively binds to the angiotensin II AT 1 receptor to inhibit the actions of angiotension II and results in lowering blood pressure(BP)[2].According to the drug label and literatures,azilsartan is principally absorbed in the upper parts of small intestine,and the best absorption sides are duodenum and jejunum[3-5].The volume of distribution of azilsartan is approximately 16 L and it is highly bound to human plasma proteins[6].Azilsartan is metabolized to two main metabolites by cytochrome P450 2C9 (CYP2C9).And the major pathways for the elimination of azilsartan are feces and urine[5,7].The recommended dose and maximum dose in adults are 20 mg and 40 mg taken orally per day.Compared with olmesartan and valsartan at maximal approved doses,azilsartan has superior eff i cacy at its maximal dose[8]and no signif i cant increases in adverse events(cardiovascular,cerebrovascular and renal events)are observed[9,10].Azilsartan shows sustaining reduction in BP even after 24 h administrated to rat and dog[11].What's more,azilsartan is well tolerated in patients with hypertension[12].

    At present,most literatures about azilsartan or azilsartan medoxomil focus on its antihypertensive eff i cacy and safety [13-16].For future pharmacokinetics study,the method to quantify the concentration of azilsartan in plasma is needed. However,there is no reported UPLC-MS/MS method for determination of azilsartan in plasma.

    In this study,methanol was added to the plasma sample to precipitate the protein,and the analyte and endogenous components were separated by the gradient elution.The UPLC-MS/MS methodwith simpleprocedure,high-sensitivity (LLOQ=2.5 ng/ml)and short analytical time(3.5 min per sample)was f i rst developed to assay the azilsartan in beagle dog plasma and was successfully applied to the pharmacokinetic study.

    2.Materials and methods

    2.1.Materials

    Azilsartan(99.8%)was kindly provided by Weigao Pharm. Co.Ltd.(Shandong,China).Diazepam(internal standard, IS>99.0%purity)was purchased from Baoyuan Pharm.Co. Ltd.(Shanxi,China).HPLC-grade acetonitrile and methanol were obtained from Fisher Scientif i c(Pittsburgh,PA,USA). HPLC-grade Formic acid was purchased from Dikma(Richmond Hill,NY,USA).Double distilled water was used throughout the study.The azilsartan tablets(Azilva?)were purchased from Takeda Pharm.Co.Ltd.(Tokyo,Japan).The azilsartan test tablets were prepared in the laboratory.

    2.2.Instrumentation

    The UPLC-MS/MS system consisted of a Waters ACQUITY UPLC system and a Tandem Quadrupole(TQ)Detector with an electrospray ionization(ESI)interface(Waters Corp.,USA).All data were processed by MassLynx 4.1 software with the QuanLynx program(Waters Corp.,USA).

    2.3.UPLC/MS/MS conditions

    The analytical column used was Kinetex 2.6 μ XB-C18 column (50×2.1 mm,100 ?;Phenomenex,USA).The column was maintained at 30°C.The mobile phase was composed of solvent A(acetonitrile with 0.2%Formic acid)and solvent B(0.2% Formic acid).The gradient program started with 40%solvent A for 1.0 min.The percentage of solventA was increased linearly to 80%from 1.0 min to 2.5 min and was decreased linearly to 40%from 2.51 min to 3.0 min.Then the percentage of solvent A maintained 40%from 3.0 min to 3.5 min and the gradient program was completed.The f l ow was always at 0.3 ml/min in the gradient program.

    For MS detection,the electrospray ionization source was operated in a positive mode(ESI+).Cone voltage and collision energy were 20 V,14 V for azilsartan and 30 V,25 V for diazepam(internal standard,IS),respectively.The temperature and gas f l ow of de-solvent were 350°C and 650 L/h.To analyze the drugs in plasma,multiple reaction monitoring(MRM)was used at the transitions of m/z 457→279 for azilsartan and m/z 285→193 for diazepam,respectively,with a scantime of0.2 s.

    2.4.Preparation of standard and quality control(QC) samples

    The stock solutions of azilsartan and IS were prepared in methanol at 100 μg/ml and 1 mg/ml,respectively.Then they were diluted to 10 μg/ml for azilsartan and 100 ng/ml for IS with methanol-water(80:20,v/v)to obtain standard solutions. The standard solutions of azilsartan were used for preparing the calibration curve and QC samples.The calibration curve was prepared by spiking 200 μl of blank plasma with 200 μl of appropriate azilsartan standard solution and 200 μl IS standard solution.Then 400 μl of methanol was added to the sample.Finally,the calibration curve was prepared at the concentration of 2.5,5,10,20,50,200,500,1000,4000 and 5000 ng/ml.And the QC samples for azilsartan at the concentration of 5,200,4000 ng/ml was prepared as the same process.

    2.5.Plasma sample preparation

    200 μl of IS standard solution(100 ng/ml)and 200 μl of methanol-water(80:20,v/v)were added to 200 μl plasma.The mixture was vortex-mixed for 3 min.400 μl of methanol was added to the sample to precipitate the protein and then the mixture was vortex-mixed for 3 min again.After that,the sample was centrifuged at 13,000 rpm for 10 min.At the end, 5 μl supernatant was injected into the UPLC-MS/MS system.

    2.6.Method validation

    2.6.1.Selectivity

    The selectivity of the method was to distinguish and quantify the analyte in the plasma samples.To conf i rm the selectivity of the method,the chromatograms of six different batches of blank plasma and the corresponding spiked samples were compared.

    2.6.2.Calibration curve and lower limit of quantitation

    The calibration curve was determined by plotting the peak area ratio(A,area of analyte/area of IS)versus the concentration using weighted(1/C2)least square linear regression. The lower limit of quantitation(LLOQ),10 times greater than the ratio of signal-to-noise,was determined.

    2.6.3.Precision and accuracy

    The precision and accuracy expressed as relative standard deviation(RSD)and relative error(RE),respectively,were calculate by analyzing the QC samples at low(5 ng/ml),medium(200 ng/ml)and high(4000 ng/ml)concentration on three validation days.

    2.6.4.Extraction recovery and matrix effect

    Theextractionrecoveryofazilsartanwasassessedby comparing the peak areas of the extracted QC samples with those of the samples which mixed corresponding standard solutions with the extracted blank plasma.The matrix effect of azilsartan was determined by comparing the peak areas of the analyte at low,medium and high concentration in the extracted blank plasma with those of the correspondingstandard solutions.The recovery and matrix effect of diazepam(IS)were also determined.

    2.6.5.Stability

    The stability test was regard as an important part of the method validation.The stability of azilsartan in the plasma samples was evaluated under various conditions,including at ambient temperature(25°C)for 12 h,post-processed for 12 h, freeze-thaw cycles for 3 times and long-term stability(-20°C for 20 days).All stability tests were analyzed by QC samples (n=3)at low,medium and high concentration.

    2.7.Pharmacokinetics application

    The above-mentioned validated method was successfully used to analyze plasma samples for a pharmacokinetic study of azilsartan.The animal protocols in the study were approved by the Shenyang Pharmaceutical University Animal Care and Use Committee.

    Six healthy beagle dogs(weight 10-12 kg)were segmented into two groups randomly,and study in a crossover experimental design.The washout period is a week.Dogs were fasted for a night before the experiment,but have free access to water.Each group was administrated orally with commercial tablets(Azilva?,Reference)and self-made tablets(Test), respectively.The dosage of administration is 20 mg.

    Blood samples(2 ml)were collected in heparinized tubes from forearm vein of the dog before drug administration and at 0.25,0.5,0.75,1,1.5,2,2.5,3,4,6,8,10,14 and 24 h postdosing.Then the plasma was separated by centrifugation at 3000 rpm for 10 min and kept in the refrigerator at-20°C until analysis.

    The main pharmacokinetic parameters were calculated by the DAS 2.0 software(Mathematical Pharmacology Professional Committee of China,Shanghai,China).

    3.Results and discussion

    3.1.Optimization of LC-MS/MS condition

    Both azilsartan and diazepam(IS)are polar compounds.The electrospray ionization source was set to a positive mode (ESI+)in order to offer higher signal intensity for them.The cone voltage and collision energy of azilsartan and IS were developed for the best response of the parent and daughter ions.The protonated molecular ions[M+H]+with greatest response in the daughter-ion mass spectrum were m/z 279 for azilsartan and m/z 193 for IS as shown in Fig.1.Various mobile phases were attempted in this study.For the sake of obtaining good peak shapes with short retention time,the mobile phase consistedof 0.2%formicacid and acetonitrilewith0.2%formic acid.The gradient elution in this method was developed to ensure that the assay was not interfered by endogenous substances.

    3.2.Method validation

    3.2.1.Specif i city

    The specif i city of the analytical method was evaluated by comparing the representative MRM chromatograms of(A) blank plasma,(B)blank plasma spiked with azilsartan(at the concentration of LLOQ)and IS(100 ng/ml),(C)plasma from a dog after single oral administration of 20 mg azilsartan in Fig.2.And no endogenous interference for azilsartan or IS was observed.The analytical time was 3.50 min for each sample. The retention times of azilsartan and IS were 1.99 min and 2.11 min,respectively.

    3.2.2.Linearity and sensitivity

    The calibration curves over the concentration range of 2.5-5000 ng/ml showed a good linearity.The typical regressionequationwasshownasthefollowingequation: A=0.130049C+0.110229(correlation coeff i cient,r=0.9971), where A stands for the ratio of the peak area of analyte to the peakareaofISand C standsfortheconcentrationofazilsartan in the plasma.All correlation coeff i cients exceeded 0.9950 on three validation days.

    LLOQ was determined as 2.5 ng/ml and the precision(RSD %)and accuracy(RE%)values were 6.75%and-10.80%, respectively,within the acceptable range of±20%.

    3.2.3.Precision and accuracy

    The intra-and inter-day precision and accuracy for the determination of azilsartan were listed in Table 1.From the results,it indicated that the intra-day precision and accuracy were all less than 6%while the inter-day precision and accuracy were all less than 9%.All the results were within the acceptable range of±15%.

    3.2.4.Extraction recovery and matrix effect

    The extraction recoveries for azilsartan at low(5 ng/ml),medium(200 ng/ml)and high(4000 ng/ml)concentrations were 82.41±0.68%,98.66±11.00%,102.43±0.82%.The recovery for IS(100 ng/ml)was 91.75±0.54%(n=6).

    The matrix effects for azilsartan at three concentration levels(5,200 and 4000 ng/ml)were 105.43±8.16,99.41±3.43, and 104.37±1.99%,respectively.The matrix effects of IS was 93.66±3.76%.All the ratios of matrix effects for azilsartan and IS were within the acceptable range of±15%.The resultsshowed that no signif i cant matrix effects for azilsartan and IS were discovered in this study.

    Table 1-Precision and accuracy for the determination of azilsartan in dog plasma samples by UPLC-n=18;mean±SD). MS/MS(intra-day, 6;inter-day,n=

    Table 2-Stability of azilsartan in beagle dog plasma under various conditions(mean±SD,n=3).

    3.2.5.Stability

    The stability test was performedby analyzing replicates(n=3) of QC samples at low,medium and high concentrations under different conditions.All the data of the stability test were shown in Table 2.It suggested that the azilsartan showed a good stability in the dog plasma during the analytical procedure.

    3.3.Pharmacokinetic studies

    ThevalidatedUPLC-MS/MSmethodwasf i rstusedforthestudy of pharmacokinetic behaviors of azilsartan in beagle dogs.The mean plasma concentration-time curves for azilsartan marketed tablets(Reference)and self-made tablets(Test)after oral administration to six healthy beagle dogs are shown in Fig.3. The Tmaxand Cmaxwere obtained directly from the curves.It was clearly indicated that Cmaxwere 955.33±272.39 ng/ml for Referece and 939.68±335.41 ng/ml for Test,respectively,while theTmaxwere0.75±0.09hand1.50±0.28h.AUC0-24hvaluesfor ReferenceandtheTeswerefoundtobe3387.36±866.96ng/ml·h and 3121.05±770.54 ng/ml·h,respectively.The data were shown as mean±standard error(n=6).The relative bioavailability of Test compared with Reference was 108.53%.

    4.Conclusion

    In this study,a rapid,selective and sensitive UPLC-MS/MS method was developed for the determination of azilsartan in beagle dog plasma.The precision,extraction recovery,matrix effect and stability of this method have been validated.It has been successfully used for the pharmacokinetic study of azilsartan in beagle dog plasma for the f i rst time.

    REFERENCES

    [1]Perry M.Azilsartan medoxomil.Clin Drug Invest 2012;32:621-639.

    [2]Ojima M,Igata H,Tanaka M,et al.In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan,in receptor binding and function studies. J Pharmacol Exp Ther 2011;336:801-808.

    [3]Kawaguchi N,Ebihara T,Takeuchi T,et al.Absorption of TAK-491,a new angiotensin II receptor antagonist,in animals.Xenobiotica 2013;43:182-192.

    [4]Angeli F,Verdecchia P,Pascucci C,et al.Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension.Expert Opin Drug Met 2013;9:379-385.

    [5]U.S.Food and Drug Administration.Edarbi(azilsartan medoxomil)tablets.Available from::http://www.accessdata. fda.gov/drugsatfda_docs/label/2014/200796s006lbl.pdf.

    [6]Jones D,Jackson H,Agboton C,et al.Azilsartan medoxomil (Edarbi):the eighth angiotensin II receptor blocker.Pharm Ther 2011;36:634.

    [7]Baker WL,White WB.Azilsartan medoxomil:a new angiotensin II receptor antagonist for treatment of hypertension.Ann Pharmacother 2011;45:1506-1515.

    [8]White B,Weber A,Sica D,et al.Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.Hypertension 2011;57:413-420.

    [9]Zaiken K,Cheng M.Azilsartan medoxomil:a new angiotensin receptor blocker.Clin Ther 2011;33:1577-1589.

    [10]Taylor A,Siragy H,Nesbitt S.Angiotensin receptor blockers: pharmacology,eff i cacy,and safety.J Clin Hypertens 2011;13:677-686.

    [11]Kusumoto K,Igata H,Ojima M,et al.Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil,in rat and dog models.Eur J Clin Pharmacol 2011;669:84-93.

    [12]Sica D,White B,Weber A,et al.Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring.J Clin Hypertens 2011;13:467-472.

    [13]Rakugi H,Enya K,Sugiura K,et al.Comparison of the eff i cacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension:a randomized,double-blind clinical study.Hypertens Res 2012;35:552-558.

    [14]Bakris L,Sica D,Weber M,et al.The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure.J Clin Hypertens 2011;13: 81-88.

    [15]Bakris L,Sica D,White B,et al.Antihypertensive eff i cacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.Am J Med 2012;125.1229.e1-1229. e10.

    [16]Cushman C,Bakris L,White B,et al.Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension.Hypertension 2012;60:310-318.

    *Corresponding author.Shenyang Pharmaceutical University,No.103,Wenhua Road,Shenyang 110016,China.Tel./fax:+86 24 23986325.

    **Corresponding author.Shenyang Pharmaceutical University,No.103,Wenhua Road,Shenyang 110016,China.Tel./fax:+86 24 23986521.

    E-mail addresses:sunyinghua77@aliyun.com(Y.Sun),xrzhxr@126.com(X.Zhang).

    Peer review under responsibility of Shenyang Pharmaceutical University.

    http://dx.doi.org/10.1016/j.ajps.2014.10.004

    1818-0876/?2015 Shenyang Pharmaceutical University.Production and hosting by Elsevier B.V.This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).

    UPLC-MS/MS

    Pharmacokinetics study

    日日爽夜夜爽网站| 日韩欧美 国产精品| 99国产极品粉嫩在线观看| 国产精品久久久人人做人人爽| 91成年电影在线观看| 亚洲精品久久国产高清桃花| 精品欧美一区二区三区在线| 级片在线观看| xxxwww97欧美| 精品无人区乱码1区二区| 嫁个100分男人电影在线观看| 在线观看午夜福利视频| 日韩大码丰满熟妇| 美女 人体艺术 gogo| 午夜激情福利司机影院| 欧美另类亚洲清纯唯美| 国产精品98久久久久久宅男小说| 99re在线观看精品视频| 最近最新中文字幕大全免费视频| 欧美另类亚洲清纯唯美| 欧美激情久久久久久爽电影| 99re在线观看精品视频| 人成视频在线观看免费观看| 亚洲欧洲精品一区二区精品久久久| 亚洲自偷自拍图片 自拍| 人人妻,人人澡人人爽秒播| 亚洲熟妇熟女久久| 精品一区二区三区四区五区乱码| 真人做人爱边吃奶动态| 最好的美女福利视频网| 成在线人永久免费视频| 精品欧美一区二区三区在线| 国产精品免费视频内射| 亚洲,欧美精品.| 最近最新免费中文字幕在线| 日本在线视频免费播放| 亚洲熟女毛片儿| 在线永久观看黄色视频| 欧美乱妇无乱码| 天堂影院成人在线观看| 亚洲成人久久性| 岛国视频午夜一区免费看| 18美女黄网站色大片免费观看| 免费在线观看黄色视频的| 别揉我奶头~嗯~啊~动态视频| 神马国产精品三级电影在线观看 | 日韩欧美三级三区| 丰满人妻一区二区三区视频av | 两性夫妻黄色片| 操出白浆在线播放| 国内精品久久久久精免费| 亚洲国产高清在线一区二区三| 91麻豆精品激情在线观看国产| 午夜福利在线观看吧| 午夜成年电影在线免费观看| av免费在线观看网站| 国产主播在线观看一区二区| 男插女下体视频免费在线播放| 欧美另类亚洲清纯唯美| 成人18禁在线播放| 亚洲 欧美一区二区三区| 老司机在亚洲福利影院| 18禁国产床啪视频网站| 国产熟女午夜一区二区三区| 久久精品国产综合久久久| 此物有八面人人有两片| 90打野战视频偷拍视频| 99久久综合精品五月天人人| 精品福利观看| 精品乱码久久久久久99久播| 久99久视频精品免费| 黄色毛片三级朝国网站| 亚洲成人精品中文字幕电影| 1024视频免费在线观看| 人妻丰满熟妇av一区二区三区| 不卡一级毛片| 久久久水蜜桃国产精品网| 日韩有码中文字幕| 久久久久免费精品人妻一区二区| 国产主播在线观看一区二区| tocl精华| 女人爽到高潮嗷嗷叫在线视频| 人人妻人人澡欧美一区二区| 老鸭窝网址在线观看| 亚洲人与动物交配视频| 成年人黄色毛片网站| 少妇被粗大的猛进出69影院| 午夜影院日韩av| 亚洲,欧美精品.| 亚洲av熟女| 精品一区二区三区四区五区乱码| 午夜老司机福利片| 久久久精品国产亚洲av高清涩受| 成人国语在线视频| 欧美国产日韩亚洲一区| 成人18禁在线播放| 精品久久久久久久人妻蜜臀av| 亚洲av五月六月丁香网| 丰满的人妻完整版| 国产成人aa在线观看| 精品高清国产在线一区| 午夜福利欧美成人| 免费看十八禁软件| 国产成人精品久久二区二区免费| 男人舔女人下体高潮全视频| 国产精华一区二区三区| 精品高清国产在线一区| 久久精品夜夜夜夜夜久久蜜豆 | 伦理电影免费视频| 国产爱豆传媒在线观看 | 久久久久国产精品人妻aⅴ院| 日韩精品免费视频一区二区三区| 久久久久九九精品影院| 国产99久久九九免费精品| 999久久久国产精品视频| 欧美性猛交╳xxx乱大交人| 久久草成人影院| 国产精品一区二区三区四区免费观看 | 高清在线国产一区| 日本免费一区二区三区高清不卡| 亚洲七黄色美女视频| 精品久久久久久成人av| 99久久久亚洲精品蜜臀av| 国产精品日韩av在线免费观看| 精品一区二区三区四区五区乱码| 婷婷精品国产亚洲av| 亚洲18禁久久av| 91九色精品人成在线观看| 又粗又爽又猛毛片免费看| 极品教师在线免费播放| 一本精品99久久精品77| 亚洲真实伦在线观看| 久久人妻福利社区极品人妻图片| 中文字幕最新亚洲高清| 成人国产一区最新在线观看| 亚洲精华国产精华精| www.熟女人妻精品国产| 又粗又爽又猛毛片免费看| 欧美日韩乱码在线| 99热这里只有是精品50| 免费看a级黄色片| 国产伦人伦偷精品视频| 午夜久久久久精精品| 老汉色∧v一级毛片| 午夜福利免费观看在线| 欧美成人免费av一区二区三区| 老熟妇乱子伦视频在线观看| 亚洲av美国av| 免费在线观看成人毛片| 女同久久另类99精品国产91| 久久中文字幕人妻熟女| 久久人妻av系列| 又粗又爽又猛毛片免费看| 丝袜美腿诱惑在线| 精品久久久久久久久久免费视频| 久久国产乱子伦精品免费另类| 大型av网站在线播放| 中文在线观看免费www的网站 | 久久精品国产99精品国产亚洲性色| 欧美日韩精品网址| 亚洲av日韩精品久久久久久密| 国产v大片淫在线免费观看| 久久国产精品影院| 变态另类丝袜制服| 日韩欧美在线二视频| 久久婷婷成人综合色麻豆| 露出奶头的视频| 精品日产1卡2卡| 在线观看免费视频日本深夜| 欧美日韩乱码在线| 国产精品电影一区二区三区| 久久99热这里只有精品18| 后天国语完整版免费观看| 韩国av一区二区三区四区| 一a级毛片在线观看| tocl精华| 午夜激情av网站| 哪里可以看免费的av片| 日本在线视频免费播放| av天堂在线播放| 国产精品久久视频播放| 欧美高清成人免费视频www| 国产精品香港三级国产av潘金莲| 国产av又大| 亚洲专区字幕在线| 免费高清视频大片| 日本在线视频免费播放| 伊人久久大香线蕉亚洲五| 大型av网站在线播放| 欧美一级a爱片免费观看看 | 高潮久久久久久久久久久不卡| 精品人妻1区二区| 一个人观看的视频www高清免费观看 | 一卡2卡三卡四卡精品乱码亚洲| 999久久久精品免费观看国产| 嫩草影院精品99| √禁漫天堂资源中文www| 每晚都被弄得嗷嗷叫到高潮| 久久亚洲真实| 中文资源天堂在线| 欧美黄色片欧美黄色片| 久久久久国产一级毛片高清牌| 中文亚洲av片在线观看爽| 精品久久久久久久毛片微露脸| 欧美极品一区二区三区四区| 777久久人妻少妇嫩草av网站| 国产午夜精品久久久久久| 婷婷丁香在线五月| 久久精品人妻少妇| 桃红色精品国产亚洲av| 国产精品亚洲美女久久久| 91麻豆精品激情在线观看国产| x7x7x7水蜜桃| 熟女电影av网| 欧美在线一区亚洲| 国产1区2区3区精品| 欧美黑人精品巨大| 最新在线观看一区二区三区| 国产精品久久久久久久电影 | 国产午夜精品久久久久久| 人妻久久中文字幕网| 免费无遮挡裸体视频| 美女黄网站色视频| 嫩草影院精品99| 黄色成人免费大全| 两个人免费观看高清视频| 国产亚洲av嫩草精品影院| 亚洲欧美日韩高清在线视频| 91字幕亚洲| 18禁美女被吸乳视频| 国产片内射在线| 成人特级黄色片久久久久久久| 婷婷精品国产亚洲av在线| 琪琪午夜伦伦电影理论片6080| 欧美成人免费av一区二区三区| 日韩中文字幕欧美一区二区| 色综合站精品国产| 亚洲免费av在线视频| 777久久人妻少妇嫩草av网站| 一二三四社区在线视频社区8| 免费在线观看亚洲国产| 在线十欧美十亚洲十日本专区| 国产蜜桃级精品一区二区三区| 高清毛片免费观看视频网站| 真人做人爱边吃奶动态| 啦啦啦免费观看视频1| 久久久久九九精品影院| 天堂av国产一区二区熟女人妻 | www.999成人在线观看| 亚洲一卡2卡3卡4卡5卡精品中文| 韩国av一区二区三区四区| 国内揄拍国产精品人妻在线| 午夜福利视频1000在线观看| 国产精品 欧美亚洲| 女同久久另类99精品国产91| 久久久久久大精品| 精品午夜福利视频在线观看一区| av免费在线观看网站| 国产私拍福利视频在线观看| 午夜免费激情av| xxx96com| 成人特级黄色片久久久久久久| 丰满人妻一区二区三区视频av | 99国产精品一区二区三区| 国产又色又爽无遮挡免费看| 亚洲国产精品成人综合色| 伦理电影免费视频| 久久久久久免费高清国产稀缺| 国产精品久久久人人做人人爽| 悠悠久久av| 香蕉av资源在线| 真人一进一出gif抽搐免费| 麻豆一二三区av精品| 亚洲成人久久性| 国产av不卡久久| 久久伊人香网站| 日本五十路高清| 99在线视频只有这里精品首页| 白带黄色成豆腐渣| 性色av乱码一区二区三区2| 脱女人内裤的视频| 免费电影在线观看免费观看| 法律面前人人平等表现在哪些方面| 精品人妻1区二区| 久久久国产成人免费| 婷婷亚洲欧美| 男女之事视频高清在线观看| 久久精品亚洲精品国产色婷小说| 一个人免费在线观看的高清视频| 久久 成人 亚洲| 久久久久久久久久黄片| 国产成人啪精品午夜网站| 亚洲成人精品中文字幕电影| 国产成人一区二区三区免费视频网站| 日本免费一区二区三区高清不卡| 久9热在线精品视频| 三级男女做爰猛烈吃奶摸视频| 久久精品国产亚洲av高清一级| 亚洲午夜理论影院| 露出奶头的视频| 一级毛片女人18水好多| 久久久久久久久久黄片| xxx96com| 日本精品一区二区三区蜜桃| 国产又黄又爽又无遮挡在线| 久久精品aⅴ一区二区三区四区| 国产单亲对白刺激| 国产精品久久久av美女十八| 性欧美人与动物交配| 精品电影一区二区在线| 精品熟女少妇八av免费久了| 悠悠久久av| 毛片女人毛片| 亚洲精品在线美女| 后天国语完整版免费观看| 久久香蕉精品热| 亚洲国产欧美一区二区综合| 国产精品98久久久久久宅男小说| 中亚洲国语对白在线视频| 欧美日韩瑟瑟在线播放| 国产成人精品久久二区二区91| netflix在线观看网站| 亚洲精品国产精品久久久不卡| 黄色a级毛片大全视频| 国产私拍福利视频在线观看| 观看免费一级毛片| 宅男免费午夜| 欧美大码av| 国产av一区二区精品久久| 午夜福利成人在线免费观看| 国产精品久久久av美女十八| 欧美丝袜亚洲另类 | 欧美日韩中文字幕国产精品一区二区三区| 免费一级毛片在线播放高清视频| 亚洲av日韩精品久久久久久密| 国产99久久九九免费精品| 欧美黑人欧美精品刺激| 免费观看精品视频网站| 男女床上黄色一级片免费看| 国产探花在线观看一区二区| 老汉色av国产亚洲站长工具| 啦啦啦观看免费观看视频高清| 亚洲男人天堂网一区| 精品久久久久久久久久久久久| 国产精品香港三级国产av潘金莲| √禁漫天堂资源中文www| 男女下面进入的视频免费午夜| 精品欧美一区二区三区在线| 男人舔女人下体高潮全视频| 欧美国产日韩亚洲一区| 久久精品国产清高在天天线| 日韩欧美国产在线观看| 岛国视频午夜一区免费看| 中文字幕最新亚洲高清| 88av欧美| 看免费av毛片| 亚洲精品粉嫩美女一区| 一区二区三区国产精品乱码| 听说在线观看完整版免费高清| 波多野结衣巨乳人妻| 国产亚洲欧美在线一区二区| 9191精品国产免费久久| 丝袜美腿诱惑在线| 757午夜福利合集在线观看| 亚洲精品中文字幕一二三四区| 又黄又粗又硬又大视频| 搡老妇女老女人老熟妇| www日本在线高清视频| 精品免费久久久久久久清纯| 白带黄色成豆腐渣| 又大又爽又粗| 日本黄色视频三级网站网址| 久9热在线精品视频| 两个人的视频大全免费| 精品熟女少妇八av免费久了| 伊人久久大香线蕉亚洲五| 国产成人一区二区三区免费视频网站| 国产av在哪里看| xxxwww97欧美| 午夜影院日韩av| 欧美黄色淫秽网站| 五月伊人婷婷丁香| 成人18禁在线播放| 日本精品一区二区三区蜜桃| 国产精品野战在线观看| 久久久久久久午夜电影| 亚洲一区二区三区不卡视频| 岛国在线免费视频观看| 亚洲欧美精品综合一区二区三区| 国产精华一区二区三区| 国产高清视频在线播放一区| 非洲黑人性xxxx精品又粗又长| 国产精品久久久久久亚洲av鲁大| 国产单亲对白刺激| 久久这里只有精品中国| 男女那种视频在线观看| 国产一区二区激情短视频| 国产成人精品久久二区二区免费| 少妇裸体淫交视频免费看高清 | 午夜福利免费观看在线| 久久精品亚洲精品国产色婷小说| 国产成人精品无人区| 国产黄片美女视频| 毛片女人毛片| 久久精品人妻少妇| 狂野欧美激情性xxxx| 啦啦啦免费观看视频1| 国产成人欧美在线观看| 久久这里只有精品中国| 91老司机精品| 午夜福利免费观看在线| 日本熟妇午夜| 亚洲精华国产精华精| 亚洲成人免费电影在线观看| 久久香蕉激情| 亚洲乱码一区二区免费版| 99久久综合精品五月天人人| 国产精品久久久久久精品电影| 精品第一国产精品| 天堂√8在线中文| 高潮久久久久久久久久久不卡| АⅤ资源中文在线天堂| 麻豆一二三区av精品| 久久中文字幕人妻熟女| 午夜激情av网站| 国产1区2区3区精品| 视频区欧美日本亚洲| 看黄色毛片网站| 精品国产乱码久久久久久男人| 亚洲av成人一区二区三| а√天堂www在线а√下载| 国产黄片美女视频| 后天国语完整版免费观看| 大型黄色视频在线免费观看| 精品久久蜜臀av无| 午夜福利18| 欧美另类亚洲清纯唯美| 美女高潮喷水抽搐中文字幕| 色综合婷婷激情| 国产黄色小视频在线观看| www日本在线高清视频| 免费看十八禁软件| 久久久久久九九精品二区国产 | 久久精品夜夜夜夜夜久久蜜豆 | av在线播放免费不卡| 午夜久久久久精精品| 老汉色av国产亚洲站长工具| 亚洲一区二区三区不卡视频| 色精品久久人妻99蜜桃| 老司机靠b影院| 国产日本99.免费观看| 国产不卡一卡二| 国产又黄又爽又无遮挡在线| 午夜福利免费观看在线| 婷婷亚洲欧美| 好男人在线观看高清免费视频| av在线播放免费不卡| 级片在线观看| 久久久久久久午夜电影| 国内精品一区二区在线观看| 午夜福利视频1000在线观看| 亚洲精品在线观看二区| 法律面前人人平等表现在哪些方面| 亚洲男人天堂网一区| 中文字幕高清在线视频| 岛国在线免费视频观看| 国产精品久久久久久久电影 | 日本一二三区视频观看| 久久欧美精品欧美久久欧美| 精品久久久久久成人av| 一二三四社区在线视频社区8| 黑人操中国人逼视频| 国产高清有码在线观看视频 | 亚洲国产精品成人综合色| 日本黄色视频三级网站网址| aaaaa片日本免费| 国产不卡一卡二| 99热这里只有是精品50| 久久中文字幕一级| 久久国产精品影院| 无人区码免费观看不卡| 欧美在线黄色| 午夜精品一区二区三区免费看| 亚洲狠狠婷婷综合久久图片| 日韩精品中文字幕看吧| 欧美成狂野欧美在线观看| 国产三级中文精品| 国产久久久一区二区三区| 亚洲18禁久久av| 中文资源天堂在线| 丝袜人妻中文字幕| 午夜福利在线在线| 国产激情久久老熟女| 国产欧美日韩一区二区三| 亚洲av中文字字幕乱码综合| 免费人成视频x8x8入口观看| 亚洲成人久久性| 狂野欧美激情性xxxx| 国产91精品成人一区二区三区| 男男h啪啪无遮挡| 亚洲国产精品成人综合色| 我的老师免费观看完整版| 又爽又黄无遮挡网站| 亚洲成人国产一区在线观看| 久久精品国产综合久久久| 日本 欧美在线| 老熟妇仑乱视频hdxx| 色综合欧美亚洲国产小说| 久久精品国产清高在天天线| 免费在线观看日本一区| 亚洲九九香蕉| 全区人妻精品视频| 国产亚洲欧美98| 免费av毛片视频| 一区二区三区国产精品乱码| 亚洲国产欧美一区二区综合| 久久精品人妻少妇| 欧美国产日韩亚洲一区| 亚洲av日韩精品久久久久久密| 欧美不卡视频在线免费观看 | 18禁黄网站禁片免费观看直播| 国产在线精品亚洲第一网站| 欧美日韩乱码在线| 亚洲一区二区三区色噜噜| 国产97色在线日韩免费| 欧美黄色片欧美黄色片| 又黄又粗又硬又大视频| 亚洲精品久久国产高清桃花| 国产男靠女视频免费网站| 精品久久久久久久久久久久久| 90打野战视频偷拍视频| 小说图片视频综合网站| 亚洲成a人片在线一区二区| 久久精品国产清高在天天线| 欧美日韩国产亚洲二区| 久久九九热精品免费| 欧美日本亚洲视频在线播放| 国产在线精品亚洲第一网站| 男女之事视频高清在线观看| 人妻夜夜爽99麻豆av| 少妇的丰满在线观看| 99精品欧美一区二区三区四区| 亚洲自偷自拍图片 自拍| 久久午夜亚洲精品久久| 中文字幕人成人乱码亚洲影| 一级毛片精品| 免费人成视频x8x8入口观看| 久久精品人妻少妇| 精品久久久久久久久久久久久| 天天添夜夜摸| 精品国产亚洲在线| 精品欧美一区二区三区在线| 亚洲精品粉嫩美女一区| av免费在线观看网站| 国内精品久久久久久久电影| 色综合亚洲欧美另类图片| 91九色精品人成在线观看| 禁无遮挡网站| 日韩成人在线观看一区二区三区| 看免费av毛片| 老鸭窝网址在线观看| 午夜福利在线在线| 日本一本二区三区精品| 一夜夜www| 久久婷婷成人综合色麻豆| 熟女少妇亚洲综合色aaa.| 欧美日韩中文字幕国产精品一区二区三区| 久久国产精品影院| 成人国语在线视频| 哪里可以看免费的av片| 国产精品98久久久久久宅男小说| aaaaa片日本免费| 久久久久久久久久黄片| 又黄又爽又免费观看的视频| 三级毛片av免费| 久久中文看片网| 国产成+人综合+亚洲专区| 最近在线观看免费完整版| 国产精品香港三级国产av潘金莲| 国产成人精品久久二区二区免费| 高清毛片免费观看视频网站| 美女大奶头视频| 一级毛片精品| 日韩高清综合在线| 国产精品久久久av美女十八| 国产精品野战在线观看| 丝袜人妻中文字幕| 搡老岳熟女国产| 国内精品久久久久精免费| 99久久无色码亚洲精品果冻| 国产三级中文精品| 国产在线精品亚洲第一网站| 69av精品久久久久久| 欧美又色又爽又黄视频| 淫妇啪啪啪对白视频| 啪啪无遮挡十八禁网站| 女人高潮潮喷娇喘18禁视频| 啦啦啦观看免费观看视频高清| 一级片免费观看大全| 午夜免费成人在线视频| 国内精品久久久久精免费| 老鸭窝网址在线观看| 久久人人精品亚洲av| 一级毛片女人18水好多| 午夜福利在线观看吧| 国产爱豆传媒在线观看 | 亚洲国产看品久久| 亚洲av成人一区二区三| 精品欧美国产一区二区三| 最好的美女福利视频网| 黄色丝袜av网址大全| 色综合站精品国产| 夜夜看夜夜爽夜夜摸| 国产精品久久电影中文字幕| 丝袜美腿诱惑在线|